Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL) is a type of aggressive non-Hodgkin lymphoma that affects B-cells, leading to rapid growth of tumors in lymph nodes and other organs.
We are testing a new CAR-T cell treatment for patients with relapsed and refractory B-cell cancers. The goal is to find a safe dose and understand how well it works.
Health conditions and diseases that the clinical trial is designed to study and treat.
Diffuse Large B-Cell Lymphoma (DLBCL) is a type of aggressive non-Hodgkin lymphoma that affects B-cells, leading to rapid growth of tumors in lymph nodes and other organs.
Multiple Myeloma is a cancer of plasma cells, a type of white blood cell, which leads to the production of abnormal proteins that can cause damage to bones and organs.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.